Prognostic Impact of Plasma Brain Natriuretic Peptide for Cardiac Events in Elderly Patients with Congestive Heart Failure

Gerontology ◽  
2001 ◽  
Vol 47 (1) ◽  
pp. 46-51 ◽  
Author(s):  
Koji Tamura ◽  
Nobuyuki Takahashi ◽  
Yuko Nakatani ◽  
Satoshi Onishi ◽  
Toshiji Iwasaka
2019 ◽  
Vol 13 (1) ◽  
pp. 25-29
Author(s):  
Karanvir Singh ◽  
Pooja Sikka ◽  
Vanita Suri ◽  
Rishikesh Prasad ◽  
Madhu Khullar ◽  
...  

Background Plasma brain natriuretic peptide levels were prospectively studied in pregnant women with heart disease. Methods Fifty pregnant women with heart disease and 25 controls were evaluated at 24 weeks or under, 30–32 weeks, 34 weeks or more of gestation, and 6 weeks postpartum. Adverse maternal cardiac events were hospitalization for worsening heart failure, stroke, and death. Results Thirty-eight (76%) women had rheumatic heart disease. Plasma brain natriuretic peptide levels were (in cases and controls) 118.3 ± 46.5 pg/ml and 66.3 ± 15.9 pg/ml (at 24 weeks or under), 124.8 ± 30.4 pg/ml and 68.4 ± 16.5 pg/ml (30–32 weeks), 135.8 ± 34.9 pg/ml and 68.6 ± 15.6 pg/ml (34 weeks or more), and 110.1 ± 21.9 pg/ml and 65.0 ± 16.1 pg/ml (6 weeks postpartum) (p = .0001). Eighteen women had adverse events. Of these, only 1 had a level less than 100 pg/ml, 12 were between 100 and 200 pg/ml, and 5 more than 200 pg/ml. Conclusions Plasma brain natriuretic peptide levels were higher in women with heart disease at all periods of gestation as well as six weeks postpartum. No woman with a plasma brain natriuretic peptide levels of 98 pg/ml or less had an adverse event.


Circulation ◽  
2004 ◽  
Vol 110 (13) ◽  
pp. 1780-1786 ◽  
Author(s):  
Franz Hartmann ◽  
Milton Packer ◽  
Andrew J.S. Coats ◽  
Michael B. Fowler ◽  
Henry Krum ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document